Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  El Ansary, Afaf K ^a,b,c   Ben Bacha, Abir G ^a,b   Al Ayahdi, Layla Y ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Autism; Fatty acids; Oxidative stress; Polyunsaturated fatty acids; Propionic acid; Valeric acid

Indexed keywords

ACETIC ACID; ARACHIDIC ACID; ARACHIDONIC ACID; BUTYRIC ACID; DECANOIC ACID; ELAIDIC ACID; FATTY ACID; GAMMA LINOLENIC ACID; HEXANE; HEXANOIC ACID; ICOSAPENTAENOIC ACID; LAURIC ACID; LEAD; LINOLEIC ACID; LINOLENIC ACID; OCTANOIC ACID; OLEIC ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; PROPIONIC ACID; STEARIC ACID; STEARIDONIC ACID; VALERIC ACID; BIOLOGICAL MARKER; UNSATURATED FATTY ACID;

ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; DISEASE MARKER; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; OXIDATIVE STRESS; PRESCHOOL CHILD; SAUDI ARABIA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; RECEIVER OPERATING CHARACTERISTIC;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; ROC CURVE; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY;

EID: 79954602894     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-62     Document Type: Article

References (56)

1. The neurobiological context of autism. F Keller AM Persico, Mol Neurobiol 2007 28 1 22 (Pubitemid 38156433)
2. Is medical genetics neglecting epigenetics? Beaud,, et al. Genet Med 2002 4 399 402 10.1097/00125817-200209000-00013 12394355
3. The autism diagnostic observations chedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. C Lord S Risi L Lambrecht EH Cook Jr BL Leventhal PC DiLavore A Pickles M Rutter, J Autism Dev Disord 2000 30 205 23 10.1023/A:1005592401947 11055457
4. Autism and pervasive developmental disorders. FR Volkmar C Lord A Bailey RT Schultz A Klin, J Child Psychol Psychiatry 2005 45 135 70 (Pubitemid 38196258)
5. Aetiology of autism: findings and questions. M Rutter, J Intellect Disabil Res 2005 49 231 8 10.1111/j.1365-2788.2005.00676.x 15816809 (Pubitemid 40484963)
6. Impairment of social and moral behavior related to early damage in human prefrontal cortex. SW Anderson A Bechara H Damasio D Tranel AR Damasio, Nat Neurosci 1999 2 1032 37 10.1038/14833 10526345 (Pubitemid 30599569)
7. Minireview: The biochemistry of n-3 polyunsaturated fatty acids. DB Jump, J Biol Chem 2002 277 8755 58 10.1074/jbc.R100062200 11748246 (Pubitemid 34952937)
8. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. FA Muskiet MR Fokkema A Schaafsma ER Boersma MA Crawford, J Nutr 2004 134 183 6 14704315 (Pubitemid 38057445)
9. Functional modulation of human recombinant gamma-aminobutyric acid type a receptor by docosahexaenoic acid. J Nabekura K Noguchi MR Witt M Nielson N Akaike, J Biol Chem 1998 273 11056 61 10.1074/jbc.273.18.11056 9556589 (Pubitemid 28204950)
10. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). HY Kim M Akbar A Lau L Edsall, J Biol Chem 2000 275 35215 35223 10.1074/jbc.M004446200 10903316
11. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. BL Scott NG Bazan, Proc Natl Acad Sci 1989 86 2903 07 10.1073/pnas.86.8.2903 2523075 (Pubitemid 19112648)
12. Disorders of mitochondrial fatty acyl-CoA beta-oxidation. RJ Wanders P Vreken ME den Boer FA Wijburg AH van Gennip L I'Jlst, J Inherit Metab Dis 1999 22 442 87 10.1023/A:1005504223140 10407780 (Pubitemid 29281036)
13. Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. SS Wang PM Fernhoff WH Hannon MJ Khoury, Genet Med 1999 1 332 339 11263545 (Pubitemid 129736037)
14. Mitochondrial fatty acid oxidation disorders. CR Roe JH Ding, New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, eighth 2001 2297 2326 The metabolic and molecular basis of inherited disease
15. Gestational, pathologic, and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and longchain acyl-CoA dehydrogenase deficiency in the mouse. KB Cox DA Hamm DS Millington D Matern J Vockley P Rinaldo CA Pinkert WJ Rhead JR Lindsey PA Wood, Hum Mol Genet 2001 10 2069 77 10.1093/hmg/10.19.2069 11590124 (Pubitemid 32998819)
16. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. D Bonnet D Martin P De Lonlay E Villain P Jouvet D Rabier M Brivet JM Saudubray, Circulation 1999 100 2248 2253 10577999
17. Medium-chain acyl-CoAdehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. R Ziadeh EP Hoffman DN Finegold RC Hoop JC Brackett AW Strauss EW Naylor, Pediatr Res 1995 37 675 678 10.1203/00006450-199505000-00021 7603790
18. A simple method for the isolation and purification of lipids from animal tissues. J Folch M Lees GHS Stanley, J Biol Chem 1957 226 497 509 13428781
19. The statistical evaluation of medical tests for classification and prediction. MS Pepe, 2003 28 Woxford Statistical Science Series
20. Statistical Methods in Diagnostic Medicine. XH Zhou N Obuchowski D McClish, Wiley, New York 2002
21. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. P Sharon WF Stenson, Gastroenterology 1985 88 55 63 3917261 (Pubitemid 15177640)
22. Anti-inflammatory effect of various drugs on acetic acid-induced colitis in rats. R Fitzpatrick JS Bostwick M Renzetti RG Pendeleton DL Decktor, Agents Actions 1990 30 393 402 10.1007/BF01966304 1974733 (Pubitemid 20185150)
23. A comparative analysis of two animal models of colitis in rats. T Yamada S Mashall RD Specian MB Grisham, Gastroenterology 1992 102 1524 1534 1314749
24. Animal model of colitis. IJ Zelitlin AA Norris, Mechanism of gastrointestinal inflammation BSG/SK&F Intenational, Standstead A, 1983 70
25. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. AM Sgaravatti RB Rosa PF Schuck CA Ribeiro CM Wannmacher AT Wyse CS Dutra-Filho M Wajner, Biochim Biophys Acta 2003 1639 232 238 14636955 (Pubitemid 37424037)
26. Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. A Chauhan V Chauhan W Ted Brown I Cohen, Life Sciences 2004 7 2539 2549 (Pubitemid 39195260)
27. Selected enzymes related to energy metabolism in Saudi autistic children. O Al-Mosalim A El-Ansary O Attas L Al-Ayadhi, Clin Biochem 2009 42 949 957 10.1016/j.clinbiochem.2009.04.006 19376103
28. Oxidative stress and antioxidant status in Saudi autistic children. Y Al-Gadani A El-Ansary O Attas L Al-Ayadhi, Clin Biochem 2009 42 1032 1040 10.1016/j.clinbiochem.2009.03.011 19306862
29. Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. L Ji A Chauhan w Ted Brown V Chauhan, Life Sciences 2009 85 788 793 10.1016/j.lfs.2009.10.008 19863947
30. Neuroplogical effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. DF MacFabe DP Cain KR Capote AE Franklin JE Hoffman F Boon AR Taylor M Kavaliers KP Ossenkopp, Behav Brain Res 2007 176 149 169 10.1016/j.bbr.2006.07.025 16950524 (Pubitemid 44895353)
31. Characterization of alpha-keto acid transport across blood-brain barrier in rats. AR Conn DI Fell RD Steele, Am J Physiol 1983 245 253 260
32. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. SR Shultz DF MacFabe KP Ossenkopp S Scratch J Whelan R Taylor DP Cain, Neuropharmacology 2008 54 901 911 10.1016/j.neuropharm.2008.01. 013 18395759
33. Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders. RH Thomas KA Foley JR Mepham LJ Tichenoff F Possmayer DF MacFabe, J Neurochem 2010 113 515 29 10.1111/j.1471-4159.2010.06614.x 20405543
34. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder. DF MacFabe NE Cain F Boon KP Ossenkopp DP Cain, Behav Brain Res 2011 217 47 54
35. Essential fatty acids and the brain. M Haag, Can J Psychiatry 2003 48 195 203 12728744 (Pubitemid 36603376)
36. Omega-3 fatty acids and neuropsychiatric disorders. G Young J Conquer, Reprod Nutr Dev 2005 45 1 28 10.1051/rnd:2005001 15865053 (Pubitemid 40528530)
37. Fish oil and mental health: The role of n-3 long chain polyunsaturated fatty acids in cognitive development and neurological disorders. A Assisi R Banzi C Buonocore F Capasso V Di Muzio F Michelacci D Renzo G Tafuri F Trotta M Vitocolonna S Garattini, Int Clin Psychopharmacol 2006 21 319 336 10.1097/01.yic.0000224790.98534.11 17012979 (Pubitemid 44498274)
38. Brain-specific lipids from marine, lacustrine, or terrestrial food resources: potential impact on early African Homo sapiens. CL Broadhurst Y Wang MA Crawford SC Cunnane JE Parkington WF Schmidt, Comp Biochem Physiol 2002 131 653 73 10.1016/S1096-4959(02)00002-7 (Pubitemid 34266818)
39. Maturation of the human frontal lobes. Physiological evidence for staging. RW Thatcher, Dev Neuropsychol 1991 7 397 419 10.1080/87565649109540500
40. Mapping brain maturation. AW Toga PM Thompson ER Sowell, Trends Neurosci 2006 29 148 159 10.1016/j.tins.2006.01.007 16472876
41. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. S Chalon S Vancassel L Zimmer D Guilloteau G Durand, Lipids 2001 36 937 44
42. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. J Biederman CR Petty MC Monuteaux R Fried D Byrne T Mirto T Spencer TE Wilens SV Faraone, Am J Psychiatry 2010 167 409 17 10.1176/appi.ajp.2009.09050736 20080984
43. Incorporation of chylomicron fatty acids into the developing rat brain. GJ Anderson PS Tso WE Connor, J Clin Invest 1994 93 2764 2767 10.1172/JCI117293 8201015 (Pubitemid 24177198)
44. Plasma fatty acid levels in autistic children. S Vancassel G Durand C Barthelemy B Lejeune J Martineau D Guilloteau C Andrès S Chalon, Prostaglandins Leukotr Essent Fatty Acids 2001 65 1 7 10.1054/plef.2001.0281 (Pubitemid 32783435)
45. Secondary carnitine deficiency and impaired docosahexaenoic (22:6 n-3) acid synthesis: a common denominator in thepathophysiology of diseases of oxidative phosphorylation and beta-oxidation. JP Infante VA Huszagh, FEBS Lett 2000 468 1 5 10.1016/S0014-5793(00)01083-8 10683429
46. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. A El-Ansary S Al-Daihan A Al-Dbass L Al-Ayadhi, Clin Biochem 2010 43 63 70 10.1016/j.clinbiochem.2009.09.008 19781542
47. Plasma fatty acid profiles in autism: A case-control study. MM Wiest JB German DJ Harvey SM Watkins I Hertz-Picciotto, Prostaglandins Leukotr Essent Fatty Acids 2009 80 221 227 10.1016/j.plefa.2009.01.007
48. Effects of dietary fat on food intake and brain uptake and oxidation of fatty acids. SW Wang M Wang BM Grossman RJ Martin, Physiol Behav 1994 56 517 22 10.1016/0031-9384(94)90295-X 7972402 (Pubitemid 24269574)
49. Uptake and transport of fatty acids into the brain and role of the blood-brain barrier system. GA Dhopeshwarkar JF Mead, Adv Lipid Res 1973 11 109 142 4608446
50. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons. S Patil C Chan, Neurosci Lett 2005 384 288 93 10.1016/j.neulet.2005.05.003 15939536 (Pubitemid 40836016)
51. Is lead toxicosis a reflection of altered fatty acid composition of membranes? WE Donaldson SO Knowles, Comp Biochem Physiol C Toxicol Pharmacol 1993 104 377 379 10.1016/0742-8413(93)90003-4 (Pubitemid 23167308)
52. Can antioxidants be beneficial in the treatment of lead poisoning? H Gurer N Ercal, Free Radic Biol Med 2000 29 927 45 10.1016/S0891-5849(00)00413-5 11084283
53. Antioxidant nutrients and lead toxicity. PC Hsu YL Guo, Toxicology 2002 180 33 44 10.1016/S0300-483X(02)00380-3 12324198 (Pubitemid 35248091)
54. Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan. Y Miyake S Sasaki K Tanaka W Fukushima C Kiyohara Y Tsuboi T Yamada T Oeda T Miki N Kawamura N Sakae H Fukuyama Y Hirota M Nagai, J Neurol Sci 2010 288 117 122 10.1016/j.jns.2009.09.021 19819467
55. Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk. R Takechi S Galloway MMS Pallebage-Gamarallage V Lam JCL Mamo, Prog Lipid 2010 49 159 70 10.1016/j.plipres.2009.10.004
56. Fatty acids and beta-cell toxicity. NG Morgan, Curr Opin Clin Nutr Metab Care 2009 12 117 22 10.1097/MCO.0b013e328321e423 19202382